]
Forbes: Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder
. 
Learn more

Journey Colab in the News

April 26, 2022

Forbes: Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder

Read article
scroll down
December 12, 2021

Journey Colab scores $12M to move psychedelics-based addiction

Read article
scroll down
October 29, 2021

Inside the Movement to Decolonize Pharma

Read article
scroll down
October 26, 2021

Journey Colab bags $3M from 'moonshot' fund to push new development model for psychedelic treatments

Read article
scroll down
September 29, 2021

Could Group Therapy Get a Boost from Psychedelics?

Read article
scroll down
September 14, 2021

Meet the top 14 psychedelics startups raising the most cash to develop new ways of treating depression, addiction, and more

Read article
scroll down